TERT and breast cancer: Luciferase assays showed that the risk-associated haplotype reduced TERT promoter activity significantly in Bre80 normal breast cells, ER-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cell lines (Figure 1A).